Roy Furulund - Alcadon Group Pres AS
ALCA Stock | SEK 28.20 0.20 0.71% |
Insider
Roy Furulund is Pres AS of Alcadon Group AB
Age | 63 |
Phone | 46 86 57 36 00 |
Web | https://www.alcadongroup.se |
Alcadon Group Management Efficiency
The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0774 %, meaning that it generated $0.0774 on every $100 dollars invested by stockholders. Alcadon Group's management efficiency ratios could be used to measure how well Alcadon Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Harald Bauer | SaltX Technology Holding | 66 | |
MSc MSc | Oncopeptides AB | 53 | |
Stefan Krafft | SaltX Technology Holding | N/A | |
Andrea Sorset | Goodbye Kansas Group | 45 | |
Eric Jacobson | SaltX Technology Holding | N/A | |
Peter Levin | Goodbye Kansas Group | 63 | |
Magnus Ekblad | SaltX Technology Holding | N/A | |
Linda Holmstrom | Oncopeptides AB | N/A | |
Markus Manninen | Goodbye Kansas Group | 54 | |
Lars Croon | SaltX Technology Holding | N/A | |
Peter Nygren | Oncopeptides AB | 64 | |
Ann Saeby | Goodbye Kansas Group | 61 | |
Pr MD | Oncopeptides AB | N/A | |
CarlJohan Linr | SaltX Technology Holding | 65 | |
Dave Connely | Goodbye Kansas Group | N/A | |
Karin Wintle | Goodbye Kansas Group | 39 | |
Anders Koch | Goodbye Kansas Group | N/A | |
MSc MD | Oncopeptides AB | N/A | |
Jakob Lic | Oncopeptides AB | 51 | |
Corey Blackman | SaltX Technology Holding | N/A | |
Jeanette Monero | Goodbye Kansas Group | N/A |
Management Performance
Return On Equity | 0.0774 | |||
Return On Asset | 0.0294 |
Alcadon Group AB Leadership Team
Elected by the shareholders, the Alcadon Group's board of directors comprises two types of representatives: Alcadon Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alcadon. The board's role is to monitor Alcadon Group's management team and ensure that shareholders' interests are well served. Alcadon Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alcadon Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stefan Eriksson, Business Development Manager | ||
Niklas Svensson, Chief Financial Officer | ||
Sonny Mirborn, President, Chief Executive Officer | ||
Paul Svensson, Purchasing Manager | ||
Marie Ygge, Director | ||
Mats Nyberg, Deputy Chief Executive Officer | ||
James Reid, Sales Director | ||
Pierre Fors, President CEO, Director | ||
Mikael Ljungman, Director of Sales | ||
Stefan Charette, Director | ||
Max Lundsten, Chief Officer | ||
Susanne Stengade, Member of the Management Board | ||
Roy Furulund, Pres AS | ||
Einar Feragen, Chief AS | ||
Magnus Larsson, Chief Sweden | ||
Jonas Martensson, Independent Chairman of the Board | ||
Duncan Lindsay, VP UK |
Alcadon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alcadon Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0774 | |||
Return On Asset | 0.0294 | |||
Profit Margin | 0.04 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 1.77 B | |||
Shares Outstanding | 20.61 M | |||
Shares Owned By Insiders | 38.50 % | |||
Shares Owned By Institutions | 38.99 % | |||
Price To Earning | 37.90 X | |||
Price To Book | 2.56 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alcadon Stock Analysis
When running Alcadon Group's price analysis, check to measure Alcadon Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcadon Group is operating at the current time. Most of Alcadon Group's value examination focuses on studying past and present price action to predict the probability of Alcadon Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcadon Group's price. Additionally, you may evaluate how the addition of Alcadon Group to your portfolios can decrease your overall portfolio volatility.